My Quote Request
No products added yet
6505-01-213-1145
20 Products
ROXANOL
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505012131145
NSN
6505-01-213-1145
ROXANOL
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505012131145
NSN
6505-01-213-1145
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE ORAL SOLUTION 20MG/ML 30ML PG
III PROTECTIVE STORAGE FEATURE: VAULT STORAGE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ROXANE LABS INC
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH SEPARATE DROPPER CALIBRATED IN 0.25 ML (5 MG) INCREMENTS; DROPPER SIZE 1 ML (20 MG)
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00467-3311-25
CALCIUM GLUCONATE INJECTION,USP
NSN, MFG P/N
6505012132595
NSN
6505-01-213-2595
NDC00467-3311-25
CALCIUM GLUCONATE INJECTION,USP
NSN, MFG P/N
6505012132595
NSN
6505-01-213-2595
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.465 MILLIEQUIVALENTS CALCIUM ION PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL WITH FLIP-TOP
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00585-0835-90
METOLAZONE TABLETS,USP
NSN, MFG P/N
6505012132667
NSN
6505-01-213-2667
NDC00585-0835-90
METOLAZONE TABLETS,USP
NSN, MFG P/N
6505012132667
NSN
6505-01-213-2667
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METOLAZONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOLAZONE TABLETS 10MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR USE AS A DIURETIC
Related Searches:
NDC53014-0835-90
METOLAZONE TABLETS,USP
NSN, MFG P/N
6505012132667
NSN
6505-01-213-2667
NDC53014-0835-90
METOLAZONE TABLETS,USP
NSN, MFG P/N
6505012132667
NSN
6505-01-213-2667
MFG
UCB MANUFACTURING INC. DBA FOREIGN PARENT IS CELLTECH GROUP PLC SLOUGH ENGLAND.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METOLAZONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOLAZONE TABLETS 10MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR USE AS A DIURETIC
Related Searches:
ZAROXOLYN
METOLAZONE TABLETS,USP
NSN, MFG P/N
6505012132667
NSN
6505-01-213-2667
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METOLAZONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOLAZONE TABLETS 10MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR USE AS A DIURETIC
Related Searches:
NDC60977-0451-03
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012132674
NSN
6505-01-213-2674
NDC60977-0451-03
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012132674
NSN
6505-01-213-2674
MFG
CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOCLOPRAMIDE INJECTION USP 5MG/ML 30ML VIAL 25S PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SINGLE DOSE VIAL; PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
DARVOCET N-50
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012133898
NSN
6505-01-213-3898
DARVOCET N-50
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012133898
NSN
6505-01-213-3898
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00002-0351-02
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012133898
NSN
6505-01-213-3898
NDC00002-0351-02
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012133898
NSN
6505-01-213-3898
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00074-1559-10
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012136008
NSN
6505-01-213-6008
NDC00074-1559-10
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012136008
NSN
6505-01-213-6008
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION USP 10ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
2921
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012136195
NSN
6505-01-213-6195
2921
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012136195
NSN
6505-01-213-6195
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
OVERALL STRENGTH IN SYSTEM: 12.5 MG PER SYSTEM
SPECIAL FEATURES: 100S;
USUAL DOSE: 2.5 MG RELEASED PER 24 HOURS
Related Searches:
NDC00083-2025-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012136195
NSN
6505-01-213-6195
NDC00083-2025-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012136195
NSN
6505-01-213-6195
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
OVERALL STRENGTH IN SYSTEM: 12.5 MG PER SYSTEM
SPECIAL FEATURES: 100S;
USUAL DOSE: 2.5 MG RELEASED PER 24 HOURS
Related Searches:
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012136195
NSN
6505-01-213-6195
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012136195
NSN
6505-01-213-6195
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
OVERALL STRENGTH IN SYSTEM: 12.5 MG PER SYSTEM
SPECIAL FEATURES: 100S;
USUAL DOSE: 2.5 MG RELEASED PER 24 HOURS
Related Searches:
COLYTE
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505012137113
NSN
6505-01-213-7113
COLYTE
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505012137113
NSN
6505-01-213-7113
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE ACTIVE INGREDIENT AND 227.100 GRAMS POLYETHYLENE GLYCOL 3350 ACTIVE
EXTERIOR CONTAINER CUBIC MEASURE: 0.750 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 25
EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: PACKET A CONTAINS 227.1 GM POLYETHYLENE GLYCOL,PACKET B CONTAINS 2.82 GM POTASSIUM CHLORIDE,PACKET C CONTAINS 6.36 GM SODIUM BICARBONATE,PACKET D CONTAINS 5.53 GM SODIUM CHLORIDE,AND PACKET E CONTAINS 21.5 GM SODIUM SULFATE
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: FOR RECONSTITUTION TO 1 GALLON WITH DEIONIZED OR DISTILLED WATER TO A ISOSMOTIC SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 5
UNIT OF ISSUE CUBE: 0.030 CUBIC FEET
UNIT OF ISSUE WEIGHT: 0.72 POUNDS
UNIT PACKAGE TYPE: PACKAGE
~1: INGREDIENT
Related Searches:
NDC00021-0001-02
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505012137113
NSN
6505-01-213-7113
NDC00021-0001-02
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505012137113
NSN
6505-01-213-7113
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE ACTIVE INGREDIENT AND 227.100 GRAMS POLYETHYLENE GLYCOL 3350 ACTIVE
EXTERIOR CONTAINER CUBIC MEASURE: 0.750 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 25
EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: PACKET A CONTAINS 227.1 GM POLYETHYLENE GLYCOL,PACKET B CONTAINS 2.82 GM POTASSIUM CHLORIDE,PACKET C CONTAINS 6.36 GM SODIUM BICARBONATE,PACKET D CONTAINS 5.53 GM SODIUM CHLORIDE,AND PACKET E CONTAINS 21.5 GM SODIUM SULFATE
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: FOR RECONSTITUTION TO 1 GALLON WITH DEIONIZED OR DISTILLED WATER TO A ISOSMOTIC SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 5
UNIT OF ISSUE CUBE: 0.030 CUBIC FEET
UNIT OF ISSUE WEIGHT: 0.72 POUNDS
UNIT PACKAGE TYPE: PACKAGE
~1: INGREDIENT
Related Searches:
NDC51263-0001-02
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505012137113
NSN
6505-01-213-7113
NDC51263-0001-02
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505012137113
NSN
6505-01-213-7113
MFG
EDLAW PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE ACTIVE INGREDIENT AND 227.100 GRAMS POLYETHYLENE GLYCOL 3350 ACTIVE
EXTERIOR CONTAINER CUBIC MEASURE: 0.750 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 25
EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: PACKET A CONTAINS 227.1 GM POLYETHYLENE GLYCOL,PACKET B CONTAINS 2.82 GM POTASSIUM CHLORIDE,PACKET C CONTAINS 6.36 GM SODIUM BICARBONATE,PACKET D CONTAINS 5.53 GM SODIUM CHLORIDE,AND PACKET E CONTAINS 21.5 GM SODIUM SULFATE
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: FOR RECONSTITUTION TO 1 GALLON WITH DEIONIZED OR DISTILLED WATER TO A ISOSMOTIC SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 5
UNIT OF ISSUE CUBE: 0.030 CUBIC FEET
UNIT OF ISSUE WEIGHT: 0.72 POUNDS
UNIT PACKAGE TYPE: PACKAGE
~1: INGREDIENT
Related Searches:
0595
CHLORPHENIRAMINE MA
NSN, MFG P/N
6505012137945
NSN
6505-01-213-7945
MFG
PHARMACEUTICAL BASICS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 4 OZ; EACH 5 ML CONTAINS CHLORPHENIRAMINE MALEATE 2 MG AND PHENYLEPHRINE HYDROCHLORIDE 5 MG; FRUIT FLAVOR
Related Searches:
BAYHISTINE ELIXIR
CHLORPHENIRAMINE MA
NSN, MFG P/N
6505012137945
NSN
6505-01-213-7945
BAYHISTINE ELIXIR
CHLORPHENIRAMINE MA
NSN, MFG P/N
6505012137945
NSN
6505-01-213-7945
MFG
PHARMACEUTICAL BASICS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 4 OZ; EACH 5 ML CONTAINS CHLORPHENIRAMINE MALEATE 2 MG AND PHENYLEPHRINE HYDROCHLORIDE 5 MG; FRUIT FLAVOR
Related Searches:
NDC12280-0595-02
CHLORPHENIRAMINE MA
NSN, MFG P/N
6505012137945
NSN
6505-01-213-7945
MFG
PHARMACEUTICAL BASICS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 4 OZ; EACH 5 ML CONTAINS CHLORPHENIRAMINE MALEATE 2 MG AND PHENYLEPHRINE HYDROCHLORIDE 5 MG; FRUIT FLAVOR
Related Searches:
BRICANYL TABLETS
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012138660
NSN
6505-01-213-8660
BRICANYL TABLETS
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012138660
NSN
6505-01-213-8660
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: BRICANYL BY MERRILL DOW PHARM.,INC.
Related Searches:
NDC00068-0750-71
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012138660
NSN
6505-01-213-8660
NDC00068-0750-71
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012138660
NSN
6505-01-213-8660
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: BRICANYL BY MERRILL DOW PHARM.,INC.
